ConvaTec Looks to Raise $1.8 Billion in London IPO
Oct 3 -- ConvaTec Ltd, a wound and ostomy care products maker, said an initial public offering of its shares on the London Stock Exchange is expected to raise about $1.8 billion, signalling a return of IPOs that were put on the back burner due to concerns over Brexit.
The IPO is the biggest in healthcare technologies sector on the LSE and also in the UK so far this year, according to Thomson Reuters Eikon data.
ConvaTec, which was sold by Bristol-Myers Squibb Co to private-equity firms for $4.1 billion in 2008, did not say how many shares it would sell, or the expected price range.
The IPO is the biggest in healthcare technologies sector on the LSE and also in the UK so far this year, according to Thomson Reuters Eikon data.
ConvaTec, which was sold by Bristol-Myers Squibb Co to private-equity firms for $4.1 billion in 2008, did not say how many shares it would sell, or the expected price range.